Search in:

Rare Diseases Volume 4, 2016 - Issue 1

Journal homepage

Open access

1,828

Views

CrossRef citations to date

Altmetric

Addendum

The calpain-suppressing effects of olesoxime in Huntington's disease

Jonasz J. WeberInstitute of Medical Genetics and Applied Genomics, University of Tuebingen, Tuebingen, Germany;Centre for Rare Diseases, University of Tuebingen, Tuebingen, Germany

Midea M. Ortiz RiosInstitute of Medical Genetics and Applied Genomics, University of Tuebingen, Tuebingen, Germany;Centre for Rare Diseases, University of Tuebingen, Tuebingen, Germany

Olaf RiessInstitute of Medical Genetics and Applied Genomics, University of Tuebingen, Tuebingen, Germany;Centre for Rare Diseases, University of Tuebingen, Tuebingen, Germany

Laura E. ClemensInstitute of Medical Genetics and Applied Genomics, University of Tuebingen, Tuebingen, Germany;Centre for Rare Diseases, University of Tuebingen, Tuebingen, Germany

Huu P. NguyenInstitute of Medical Genetics and Applied Genomics, University of Tuebingen, Tuebingen, Germany;Centre for Rare Diseases, University of Tuebingen, Tuebingen, GermanyCorrespondence[email protected]

Article: e1153778 | Received 02 Dec 2015, Accepted 04 Feb 2016, Published online: 06 Apr 2016

Cite this article
https://doi.org/10.1080/21675511.2016.1153778
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (11)

Catherine A. Bellissimo, Luca J Delfinis, Meghan C Hughes, Patrick C Turnbull, Shivam Gandhi, Sara N DiBenedetto, Fasih A Rahman, Peyman Tadi, Christina A Amaral, Ali Dehghani, James Cobley, Joe Quadrilatero, Uwe Schlattner & Christopher G.R. Perry. (2023) Mitochondrial creatine sensitivity is lost in the D2.mdx model of Duchenne muscular dystrophy and rescued by the mitochondrial-enhancing compound Olesoxime. American Journal of Physiology-Cell Physiology.
Crossref

Jingyun Wu, Luisa Möhle, Thomas Brüning, Iván Eiriz, Muhammad Rafehi, Katja Stefan, Sven Marcel Stefan & Jens Pahnke. (2022) A Novel Huntington’s Disease Assessment Platform to Support Future Drug Discovery and Development. International Journal of Molecular Sciences 23:23, pages 14763.
Crossref

Rana Dilara Incebacak Eltemur, Huu Phuc Nguyen & Jonasz Jeremiasz Weber. (2022) Calpain-mediated proteolysis as driver and modulator of polyglutamine toxicity. Frontiers in Molecular Neuroscience 15.
Crossref

Jonasz Jeremiasz Weber, Stefanie Cari Anger, Priscila Pereira Sena, Rana Dilara Incebacak Eltemur, Chrisovalantou Huridou, Florian Fath, Caspar Gross, Nicolas Casadei, Olaf Riess & Huu Phuc Nguyen. (2022) Calpains as novel players in the molecular pathogenesis of spinocerebellar ataxia type 17. Cellular and Molecular Life Sciences 79:5.
Crossref

Takuro Miyazaki, Risako Akasu & Akira Miyazaki. (2020) Calpain proteolytic systems counteract endothelial cell adaptation to inflammatory environments. Inflammation and Regeneration 40:1.
Crossref

Álvaro Sebastián‐Serrano, Ana Simón‐García, Alicia Belmonte‐Alfaro, Julia Pose‐Utrilla, María Santos‐Galindo, Ana del Puerto, Lucía García‐Guerra, Ivó H. Hernández, Giampietro Schiavo, Miguel R. Campanero, José J. Lucas & Teresa Iglesias. (2019) Differential regulation of Kidins220 isoforms in Huntington's disease. Brain Pathology 30:1, pages 120-136.
Crossref

Igor Krivoi & Alexey Petrov. (2019) Cholesterol and the Safety Factor for Neuromuscular Transmission. International Journal of Molecular Sciences 20:5, pages 1046.
Crossref

Jonasz Jeremiasz Weber, Priscila Pereira Sena, Elisabeth Singer & Huu Phuc Nguyen. (2019) Killing Two Angry Birds with One Stone: Autophagy Activation by Inhibiting Calpains in Neurodegenerative Diseases and Beyond. BioMed Research International 2019, pages 1-13.
Crossref

D. D. O. Martin, C. Kay, J. A. Collins, Y. T. Nguyen, R. A. Slama & M. R. Hayden. (2018) A human huntingtin SNP alters post-translational modification and pathogenic proteolysis of the protein causing Huntington disease. Scientific Reports 8:1.
Crossref

J. Stricker-Shaver, A. Novati, L. Yu-Taeger & H. P. Nguyen. 2018. Polyglutamine Disorders. Polyglutamine Disorders 29 57 .

Yasuko Ono, Takaomi C. Saido & Hiroyuki Sorimachi. (2016) Calpain research for drug discovery: challenges and potential. Nature Reviews Drug Discovery 15:12, pages 854-876.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

The calpain-suppressing effects of olesoxime in Huntington's disease

Articles from other publishers (11)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

The calpain-suppressing effects of olesoxime in Huntington's disease

Citations (11)

Articles from other publishers (11)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date